Day: May 27, 2021

eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies

Written by Customer Service on May 27, 2021. Posted in Mergers And Acquisitions.

Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust Anticipated cash resources will fund eFFECTOR’s pipeline advancement through multiple clinical milestones Merger expected to be completed in third quarter of 2021; combined company expected to be listed on Nasdaq under the ticker “EFTR” Webcast to discuss the proposed transaction scheduled for Thursday, May 27th at 9:00 am ETSAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (eFFECTOR), a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors (STRIs) for the treatment of cancer, and Locust Walk Acquisition Corp. (NASDAQ: LWAC), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced they...

Earth Alive First Quarter 2021 Results Continue to Improve Sequentially

Written by Customer Service on May 27, 2021. Posted in Earnings Releases And Operating Results.

MONTREAL, May 27, 2021 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (“Earth Alive” or the “Company”), a Canadian soil health company that develops and manufactures advanced microbial technology products, this morning reported results for the three-month period ended March 31, 2021. All financial information herein is in Canadian dollars unless otherwise noted. Business Highlights$5 million non-brokered private placement completed on February 26, 2021 with net proceeds to be used to grow the size of the team, to fund operational projects including R&D as well as and the growth of the business, and for general corporate purposes. US$500,000 purchase order for the ea1TM dust suppressant (“ea1”) announced on March 30, 2021, the fourth consecutive order since November 2018 by this customer for its mine...

BioSyent Releases Financial Results for Q1 2021

Written by Customer Service on May 27, 2021. Posted in Earnings Releases And Operating Results.

MISSISSAUGA, Ontario, May 27, 2021 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2021. Key highlights include:Record first quarter (Q1) 2021 Net Revenues of $7,419,889 increased by 22% versus Q1 2020 Q1 2021 Canadian Pharmaceutical Net Revenues of $6,233,763 increased by 5% versus Q1 2020 Q1 2021 International Pharmaceutical Net Revenues of $1,140,279 increased by 1,578% versus Q1 2020 Q1 2021 EBITDA1 of $2,359,085 increased by 18% versus Q1 2020 Q1 2021 EBITDA percentage to Net Revenues of 32% compares to 33% in Q1 2020 Q1 2021 Net Income After Taxes (NIAT) of $1,664,368 increased by 15% versus Q1 2020 Q1 2021 NIAT percentage to Net Revenues of 22% compares to 24% in Q1 2020 Q1 2021 Fully Diluted EPS of $0.13 was $0.02 higher than Q1 2020...

Ackroo releases Q1 2021 Financial Results

Written by Customer Service on May 27, 2021. Posted in Earnings Releases And Operating Results.

Ackroo achieves 13th consecutive positive EBITDA quarter HAMILTON, Ontario, May 27, 2021 (GLOBE NEWSWIRE) — Ackroo Inc. (the “Company” or “Ackroo”) (TSX-V: AKR) (OTC: AKRFF), a loyalty marketing, payments and point-of-sale technology and services provider, has filed its financial results for the period ended March 31, 2021. The results for the period ended March 31, 2021 reflect the Company’s 13th consecutive adjusted EBITDA positive quarter and includes 82% of the revenue being recurring with an 88% gross profit margin. Throughout the quarter, the Company normalized the recently acquired GGGolf business to position the new AckrooPOS business unit for growth. “Although Q1 was very challenging for Ackroo I am happy with several of the obstacles overcome and tasks completed to set us up for continued success,” said Steve Levely,...

Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010

Written by Customer Service on May 27, 2021. Posted in Public Companies.

Drs. Mark Humayun and Firas Rahhal, leading retinal specialists and Advisors to Outlook Therapeutics, stress clinical value of ONS-5010, if approved, over existing treatment options Registration clinical program and pre-commercialization planning for ONS-5010 remains ongoing with key catalysts expected over the next year Webcast replay is now available: click hereISELIN, N.J., May 27, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, hosted a virtual Clinical Day on May 20, 2021 to provide an update on the clinical progress of ONS-5010 (bevacizumab-vikg) for treatment of wet age-related macular degeneration (wet AMD). If approved, ONS-5010 will be the...

Ayurcann Expansion Continues with New Partnership

Written by Customer Service on May 27, 2021. Posted in Public Companies.

Company set to provide and manufacture products for Joints Cannabis TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”), a Canadian extraction company specializing in the processing of cannabis and hemp to produce oils and various derivative products, is pleased to announce that it has entered into a supply and manufacturing agreement with Joints Cannabis. Continuing their impressive expansion efforts in 2021, Ayurcann has signed an agreement with Joints Cannabis to supply CBD distillate, Isolate, and THC distillate for their market-leading health and wellbeing products. With market-leading CBD products like their THC free Repose T-Free Oils, their balanced Recess 1:1 Oils or their full spectrum Respite CBD Oils, Joints Cannabis products offer a selection of CBD oils that fit...

REPEAT — MediPharm Labs Launches High-CBD Wellness Oils in Quebec; Ships First Order of CBD 25 and CBD 50 Formulas Now Available for Retail Sale by SQDC

Written by Customer Service on May 27, 2021. Posted in Public Companies.

BARRIE, Ontario, May 27, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it launched its first wellness products in Quebec and shipped its first order of premium CBD oils for retail sale to the Société québécoise du cannabis (SQDC), the province’s sole legal retailer for cannabis based products. “As our domestic Canadian market starts to recover and the Government works towards re-opening the economy, we remain excited about our growth prospects in Quebec as we launch new products and increase our local presence,” said Keith Strachan, President and Interim CEO, MediPharm Labs. “Quebec, one of the largest consumer markets...

Captor Capital Announces Opening of ‘One Plant California’ Retail Cannabis Dispensary in Goleta, California

Written by Customer Service on May 27, 2021. Posted in Public Companies.

Captor Retail Group’s Eighth Dispensary in California to Serve Customers Throughout Santa Barbara CountyCaptor Retail Group to open eighth dispensary on Friday.Captor Retail Group to open eighth dispensary on Friday.TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (“Captor” or the “Company”), is pleased to announce it will open a brand-new retail cannabis dispensary location in Goleta, California, this month. The Santa Barbara County retail dispensary, Captor Retail Group’s eighth dispensary in California, will open Friday, May 28, 2021. The new retail dispensary will be located at 290 Storke Road, Goleta, California 93117, in a high-traffic shopping plaza with Target, Costco, and Home Depot locations nearby. The dispensary will...

Energy-Efficient LED Lighting and Controls Provider Orion Participates at Craig-Hallum Virtual Investor Conference June 2nd and Presents at LD Micro Invitational June 8th at 12:30 pm ET

Written by Customer Service on May 27, 2021. Posted in Public Companies.

MANITOWOC, Wis., May 27, 2021 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, controls and IoT systems, including turnkey project implementation, program management and system maintenance, will participate at the 18th Annual Craig-Hallum Institutional Investor Virtual Conference on Wednesday, June 2nd and will present at the LD Micro Invitational XI virtual conference on Tuesday, June 8th at 12:30 p.m. ET. Craig-HallumOrion’s CEO, Mike Altschaefl and CFO, Per Brodin will host virtual meetings with investors throughout the day on June 2nd. Please contact your Craig-Hallum representative to schedule a meeting. LD MicroManagement will present on Tuesday, June 8th from 12:30-12:55 p.m. ET, on Track 2. Investors are encouraged to register and attend the webcast:...

Water Ways Reports Q1 2021 Financial Results, Books a Profit and Record Q1 Sales of CAD$5,450,000

Written by Customer Service on May 27, 2021. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” or the “Company“), a global provider of proprietary water irrigation technology solutions to agricultural producers, announces the filing of its Financial Statements (“Statements“) and Managements Discussion and Analysis (“MD&A“) for the three months period ended March 31, 2021. A comprehensive discussion of Water Ways’ financial position and results of operations is provided in the MD&A. Ohad Haber, President, CEO and Chairman of the Board of Water Ways states: “Our business has improved dramatically on all fronts in Q1 of 2021. We achieved record Q1 sales and revenue growth, which is a testament...

Day: May 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals